LLYbenzinga

Eli Lilly And Novo Nordisk Could Face Policy Shifts As FDA Oversight, Tariff Risks Mount

Summary

Needham hosted an expert to discuss potential impact of trade tariffs and personnel changes on healthcare equities. Generic drug market may be negatively affected.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 7, 2025 by benzinga